Integrated Wealth Concepts LLC Regeneron Pharmaceuticals, Inc. Transaction History

Integrated Wealth Concepts LLC

$7.83 Billion
Q3 2024

A detailed history of Integrated Wealth Concepts LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 748 shares of REGN stock, worth $563,266. This represents 0.01% of its overall portfolio holdings.

Number of Shares

748

Previous 534 40.07%

Holding current value

$563,266

Previous $561,000 40.11%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $219,155 - $257,176	214 Added 40.07%	748 $786,000
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $26,496 - $32,135	30 Added 5.95%	534 $561,000
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $92,074 - $101,321	102 Added 25.37%	504 $485,000
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $42,634 - $48,493	-55 Reduced 12.04%	402 $353,000
Q3 2023 Nov 15, 2023	SELL	$692.45 - $844.37 $24,928 - $30,397	-36 Reduced 7.3%	457 $376,000
Q2 2023 Aug 15, 2023	BUY	$700.03 - $830.35 $3,500 - $4,151	5 Added 1.02%	493 $354,000
Q1 2023 May 03, 2023	BUY	$680.49 - $826.97 $96,629 - $117,429	142 Added 41.04%	488 $401,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $124,236 - $134,884	-176 Reduced 33.72%	346 $250,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $297,316 - $375,197	-518 Reduced 49.81%	522 $360,000
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $269,788 - $363,509	492 Added 89.78%	1,040 $615,000
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $9,521 - $11,174	-16 Reduced 2.84%	548 $383,000
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $10,326 - $12,748	19 Added 3.49%	564 $356,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $67,735 - $80,353	118 Added 27.63%	545 $330,000
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $201,885 - $238,496	427 New	427 $238,000
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $243,914 - $299,317	-546 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $31,089 - $39,518	65 Added 13.51%	546 $264,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $15,253 - $18,429	28 Added 6.18%	481 $269,000
Q2 2020 Jul 30, 2020	BUY	$493.32 - $643.92 $223,473 - $291,695	453 New	453 $283,000

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.

Account

Integrated Wealth Concepts LLC Regeneron Pharmaceuticals, Inc. Transaction History